Literature DB >> 26851010

HSV-1 Infection Modulates the Radioresponse of a HPV16-positive Head and Neck Cancer Cell Line.

Aaro Turunen1, Veijo Hukkanen2, Jarmo Kulmala3, Stina Syrjanen4.   

Abstract

BACKGROUND: The combined effects of Human papillomavirus (HPV) and Herpes simplex type 1 (HSV-1) infections and their effects on cancer cell radioresistance are unexplored.
MATERIALS AND METHODS: An HPV16-positive hypopharyngeal carcinoma cell line (UD-SCC-2) was infected with wt-HSV-1 at low multiplicity of infection (MOI) and irradiated with 2 Gy at 24 h postinfection. Viability assays and quantitative reverse-transcriptase PCR for HPV16 E6, E7, nuclear factor kappa B1, B-cell CLL/lymphoma 2 (BCL2), and caspases 3, 8 and 9 at 24, and 72 h, as well as immunocytochemistry for BCL2, caspase 3, cyclin E, mouse double minute 2 homolog (MDM2), HSV-1 and Ki-67 were performed at 144 h postirradiation.
RESULTS: At 144 h, cell viability was significantly lowered by irradiation only in uninfected cells. Infection combined with irradiation resulted in increased expression of E6, E7, BCL2 and NF-κB1 at 144 h. Simultaneously, E6 and E7 were down-regulated in non-irradiated infected cells. Irradiation and infection with 0.00001 MOI separately up-regulated caspase 3 but infection with 0.0001 MOI halved its expression in irradiated cells.
CONCLUSION: HSV-1 infection modulates radioresistance of HPV16-positive hypopharyngeal carcinoma cells. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  HSV-1; head and neck cancer; herpes simplex virus; human papillomavirus; irradiation; radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 26851010

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Herpesviruses in Head and Neck Cancers.

Authors:  Mikołaj Wołącewicz; Rafał Becht; Ewelina Grywalska; Paulina Niedźwiedzka-Rystwej
Journal:  Viruses       Date:  2020-02-03       Impact factor: 5.048

2.  Enzymatically synthesized 2'-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity.

Authors:  Alesia A Levanova; Kiira M Kalke; Liisa M Lund; Nina Sipari; Mohammadreza Sadeghi; Marie C Nyman; Henrik Paavilainen; Veijo Hukkanen; Minna M Poranen
Journal:  Antiviral Res       Date:  2020-08-13       Impact factor: 5.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.